근거중심한의약 DB
Home > 한의약융합데이터센터 > 근거중심한의약 DBTitle | Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. |
---|---|
Authors | Jia R, Liu N, Cai G, Zhang Y, Xiao H, Zhou L, Ji Q, Zhao L, Zeng P, Liu H, Huo J, Yue X, Zhang Y, Wu C, Sun X, Feng Y, Liu H, Liu H, Han Z, Lai Y, Zhang Y, Han G, Gong H, Wang Y, Li Q. |
Journal | Front Oncol. |
Year | 2021 |
Vol (Issue) | 11 |
Page | 618793. |
doi | 10.3389/fonc.2021.618793. |
PMID | |
Url | |
MeSH | |
Keywords | Chinese herbal medicine; cancer recurrence and metastasis; clinical trial; colon cancer; disease-free survival |
한글 키워드 | 한약 치료; 암 재발 및 전이; 임상시험; 대장암; 무병 생존기간 |
KMCRIC Summary & Commentary |
|
Korean Study | |
Abstract | Background: Chemotherapy is the standard adjuvant treatment for colon cancer. Chinese herbal formula PRM1201 improves the efficacy of chemotherapy when used in combination with Cetuximab or Bevacizumab in patients with metastatic colorectal cancer. This study aims to explore the benefits of treatment with chemotherapy plus PRM1201 in the postoperative adjuvant setting. |
국문초록 | |
Language | 영어 |
첨부파일 |